FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years

SAN FRANCISCO and DUBLIN October 28, 2019– Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced that...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news